Home » Topics » BioWorld Science

BioWorld Science
RSS

Wee1 is a target in rhabdomyosarcoma

Aug. 24, 2018

Gene therapy for dominant blindness

Aug. 24, 2018

Phase III SOLAR-1 study of BYL-719 in breast cancer meets PFS primary endpoint

Aug. 23, 2018

AbbVie reports topline results from phase III extension study with elagolix for uterine fibroids

Aug. 23, 2018

Impel initiates phase III study of INP-104 for migraine

Aug. 23, 2018

Nuevolution reveals lead discovery program targeting inhibition of IL-17A using small molecules

Aug. 23, 2018

FDA approves Oxervate for neurotrophic keratitis

Aug. 23, 2018

UP Therapeutics identifies proteasome inhibitors

Aug. 23, 2018

Jupiter Orphan Therapeutics announces favorable Jotrol preclinical data

Aug. 23, 2018

Merck & Co. patents HIV integrase inhibitors

Aug. 23, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...